Overview:

Continuing from the previous edition, the track aims to offer scientific advancements, diagnostic technologies, and full automation in clinical chemistry to avoid errors in the laboratory. This year the track will focus on topics such as biomarkers, pathogens and updates on antimicrobial resistance featuring local and international experts.

Key topics:

• New Biomarkers in acute kidney injury
• Emerging Pathogens
• Liquid Biopsy

Scientific Chair:

• Chair - Dr Fayha Ahmed, Consultant and Head of Routine Biochemistry Unit, Pathology & Genetics Department, Dubai Hospital, Dubai, UAE
• Co-Chair - Dr Laila Abdel Wareth, Chief, Clinical Pathology, Cleveland Clinic Abu Dhabi, Abu Dhabi, UAE

Key speakers:

• Prof Khosrow Adeli, President, IFCC, Toronto, Ontario, Canada

Benefits of attending:

• Discover how can new biomarkers be integrated into routine clinical practice to prevent and manage acute kidney injury.
• Review various pathogens and their common traits to avoid any underlying epidemiology
• Determine liquid biopsy and its advantages to detect cancer at an early stage